- Retraction Note
- Open Access
Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
European Journal of Medical Research volume 20, Article number: 38 (2015)
- The original article was published in European Journal of Medical Research 2013 18:59
The Publisher and Editor regretfully retract this article  because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.
Wang Q, Zhou J, Zhong D, Wang Q, Huang J. Ferroportin in the progression and prognosis of hepatocellular carcinoma. Eur J Med Res. 2013;18:59.
The online version of the original article can be found under doi:10.1186/2047-783X-18-59.
About this article
Cite this article
Wang, Q., Zhou, J., Zhong, D. et al. Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma. Eur J Med Res 20, 38 (2015). https://doi.org/10.1186/s40001-015-0132-6